Our structured development process arrives at scalable solutions in efficient timeframes. Please note that timelines are indicative and can vary based on scope, complexity, and specific requirements.
STEP 1
INQUIRY
We review your requirements and schedule a call to align on scope, quantity, and timeline. This sets the foundation for a feasibility assessment.
3-5 days
STEP 2
FEASIBILITY
Our team designs a small-scale trial tailored to your specifications, testing yield and purity before committing to larger production.
2–4 Weeks
STEP 3
DELIVERY
We deliver a small lab-scale batch of your glycosylated molecule, giving you the material needed to test whether glycosylation improves its performance, before you decide to move forward with scale-up.
6–8 weeks
STEP 4
SCALABILITY
Once validated, we scale production using the same proven process, moving smoothly from small batches to full commercial volumes.
16–24 weeks
Benefits
Biopharma
In vitro glycoengineering tailors glycosylation after production: our enzymes add the glycans to your purified molecule, so your upstream process no longer dictates your glycan profile. Express in any cell line, then install defined terminal sialic acid to extend half-life and unlock anti-inflammatory activity. More uniform glycoforms, better batch-to-batch consistency, fewer non-human glycans — integrated into existing production without changing the process. Research-grade today, GMP-grade from 2027.
Extend your drug's half-life by up to
3x
Boost anti-inflammatory potency up to
10-fold
Benefits
Nutrition
Sialic acid is the natural sugar coating that makes bioactive proteins work — and most of it is lost during production and purification. eversyn's enzymes put it back precisely where it belongs. That single step converts a standard protein into a differentiated, gut-active ingredient with a mechanism you can defend: more good bacteria, fewer pathogens sticking to the gut wall.
Grow beneficial gut bacteria by 45%
+45%
Slash harmful pathogens by up to 85%
-85%
Benefits
Personal Care
Bring us your active — we make it better. Sialic acid is a natural sugar that supports collagen and a stronger skin barrier, yet almost no cosmetic active carries it. eversyn's enzymes attach it directly to your molecule. Same ingredient, same supply chain, one new mechanism behind it — and a claim your R&D team can actually defend.
Cut water loss through skin by over
8%
Shrink visible wrinkles and boost elasticity by up to
16%
Partner Process
A modular approach to glycosylation that turns molecules into better-performing products across biopharma, nutrition, and personal care.
1
Run a Proof of Concept
Plug in glycosylation on biotherapeutics like antibodies and glycoconjugate vaccines — for better efficacy, safer profiles, and a clearer path to regulatory approval, overcoming the trade-off between yield and precision.
2
Co-Develop Novel Actives
Plug in sugar for more functional nutrition — from glycoproteins and lactoferrin to next-generation bioactive glycans that carry novel functional benefits.
3
Scale to market
Plug in sugar for higher-performance, skin-compatible ingredients — from glycolipids to next-generation glyco-actives.
Contact
Do you have a custom requirement?
Not every project fits a catalogue. If you need a specific activated sugar or glycan — a different structure, a different scale, a different grade — tell us what you're working towards and we'll tell you whether we can make it.
How long does it take to test a sugar on our molecule?
The lab-stage proof-of-effect is designed to be fast — small batches are produced quickly within weeks so customers can evaluate results before committing to larger-scale work.
What does "plug-in sugars" mean?
It refers to eversyn's ability to attach specific sugar molecules (glycans) onto a customer's existing molecule — a drug, protein, or ingredient — to change how it performs. The sugar acts like a functional add-on rather than a structural rebuild.
What is the Glyco-Plug-In Platform?
It's eversyn's proprietary technology platform for modular glycan engineering — enabling customers across biopharma, nutrition, and personal care to add functional sugars to their molecules using the same core enzymatic tool.
How does glycosylation affect antibody performance?
Glycosylation shapes antibody stability, safety, effector function, and immunogenicity — it's considered a critical quality attribute in therapeutic protein development.
Are food-grade versions available?
Yes. Food-grade qualification is available upon request for nutrition and functional food applications — contact us to discuss your specific requirements.
Does eversyn manufacture at commercial scale, or only lab scale?
Both. The same enzymatic platform is designed to work from milligram lab samples through to kilogram-scale commercial production, avoiding the traditional handoff between research suppliers, CROs, and CMOs.
Ready to unlock your molecule?
Interested in our products? We look forward to receiving your inquiry.
Get in Touch
Please note: Our products are exclusively aimed at B2B professionals for research purposes only. Delivery to private individuals is excluded.
eversyn GmbH OvGU Building 25 Universitätsplatz 2 DE-39106 Magdeburg
